BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1613814)

  • 1. Therapeutic potential for adenosine receptor activation in ischemic brain injury.
    Miller LP; Hsu C
    J Neurotrauma; 1992 May; 9 Suppl 2():S563-77. PubMed ID: 1613814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine and brain ischemia.
    Rudolphi KA; Schubert P; Parkinson FE; Fredholm BB
    Cerebrovasc Brain Metab Rev; 1992; 4(4):346-69. PubMed ID: 1486019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro autoradiographic evidence for adenosine modulation of ethanol-induced motor disturbances in rats.
    Clark M; Dar MS
    Alcohol Alcohol Suppl; 1991; 1():203-6. PubMed ID: 1845538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain.
    Jarvis MF; Schulz R; Hutchison AJ; Do UH; Sills MA; Williams M
    J Pharmacol Exp Ther; 1989 Dec; 251(3):888-93. PubMed ID: 2600819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The comparative characteristics and receptor mechanism of the effect of adenosine-receptor agonists in total cerebral ischemia].
    Kulinskiĭ VI; Usov LA; Sufianova GZ; Lidak MIu; Iurkevich AM
    Eksp Klin Farmakol; 1993; 56(6):13-6. PubMed ID: 8111286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of pharmacological sensitivity to adenosine analogs in embryonic chick heart: role of A1 adenosine receptors and adenylyl cyclase inhibition.
    Blair TA; Parenti M; Murray TF
    Mol Pharmacol; 1989 May; 35(5):661-70. PubMed ID: 2498636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The importance of brain temperature in cerebral injury.
    Dietrich WD
    J Neurotrauma; 1992 May; 9 Suppl 2():S475-85. PubMed ID: 1613807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of A(2A) adenosine receptor expression and functioning following permanent focal ischemia in rat brain.
    Trincavelli ML; Melani A; Guidi S; Cuboni S; Cipriani S; Pedata F; Martini C
    J Neurochem; 2008 Jan; 104(2):479-90. PubMed ID: 17953669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretreatment with an adenosine A1 receptor agonist and lidocaine: a possible alternative to myocardial ischemic preconditioning.
    Canyon SJ; Dobson GP
    J Thorac Cardiovasc Surg; 2005 Aug; 130(2):371-7. PubMed ID: 16077401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine A2A receptors and brain injury: broad spectrum of neuroprotection, multifaceted actions and "fine tuning" modulation.
    Chen JF; Sonsalla PK; Pedata F; Melani A; Domenici MR; Popoli P; Geiger J; Lopes LV; de Mendonça A
    Prog Neurobiol; 2007 Dec; 83(5):310-31. PubMed ID: 18023959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the effects of adenosine receptor agonists on cerebral blood flow in uninjured and traumatically injured rat brain using continuous arterial spin-labeled magnetic resonance imaging.
    Kochanek PM; Hendrich KS; Jackson EK; Wisniewski SR; Melick JA; Shore PM; Janesko KL; Zacharia L; Ho C
    J Cereb Blood Flow Metab; 2005 Dec; 25(12):1596-612. PubMed ID: 15931163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of adenosine receptor agonists on the normal cerebral blood flow and in subsequent ischemia].
    Kulinskiĭ VI; Sufianova GZ; Usov LA; Ekimov EN
    Eksp Klin Farmakol; 1996; 59(3):37-9. PubMed ID: 8974582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bradykinin receptor antagonists in cerebral ischemia and trauma.
    Zausinger S
    IDrugs; 2003 Oct; 6(10):970-5. PubMed ID: 14534854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-substituted adenosines as novel neuroprotective A(1) agonists with diminished hypotensive effects.
    Knutsen LJ; Lau J; Petersen H; Thomsen C; Weis JU; Shalmi M; Judge ME; Hansen AJ; Sheardown MJ
    J Med Chem; 1999 Sep; 42(18):3463-77. PubMed ID: 10479279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine receptors in brain: neuromodulation and role in epilepsy.
    Chin JH
    Ann Neurol; 1989 Dec; 26(6):695-8. PubMed ID: 2690732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative characteristics of A1-receptor agonists as neuroprotective agents].
    Kulinskiĭ VI; Minakina LN; Usov LA
    Eksp Klin Farmakol; 2001; 64(5):19-22. PubMed ID: 11764492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fc gamma receptor-mediated functions in neutrophils are modulated by adenosine receptor occupancy. A1 receptors are stimulatory and A2 receptors are inhibitory.
    Salmon JE; Cronstein BN
    J Immunol; 1990 Oct; 145(7):2235-40. PubMed ID: 2168919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine receptors and neurological disease: neuroprotection and neurodegeneration.
    Stone TW; Ceruti S; Abbracchio MP
    Handb Exp Pharmacol; 2009; (193):535-87. PubMed ID: 19639293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine A1 receptor agonists as clinically viable agents for treatment of ischemic brain disorders.
    Bischofberger N; Jacobson KA; von Lubitz DK
    Ann N Y Acad Sci; 1997 Oct; 825():23-9. PubMed ID: 9369972
    [No Abstract]   [Full Text] [Related]  

  • 20. Adenosine and cerebral ischemia: therapeutic future or death of a brave concept?
    Von Lubitz DK
    Eur J Pharmacol; 1999 Jan; 365(1):9-25. PubMed ID: 9988118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.